ClinicalTrials.Veeva

Menu

Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia

B

Benha University

Status

Completed

Conditions

Pre-Eclampsia

Treatments

Diagnostic Test: ELISA

Study type

Observational

Funder types

Other

Identifiers

NCT06214702
RC 7.1.2024

Details and patient eligibility

About

Evaluation of the predictability of estimated levels of Serpin C, sFlt-1 and placental growth factor (PLGF) in blood samples obtained during the 1st trimester from normotensive pregnant women for identification of women liable to develop PE during the course of pregnancy.

Enrollment

60 patients

Sex

Female

Ages

25 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normotensive pregnant women had singleton fetus presenting during the 1st trimester
  • free of exclusion criteria

Exclusion criteria

  • Age
  • Sex
  • Hypertension

Trial design

60 participants in 2 patient groups

Study group
Description:
Patients with diastolic blood pressure (DBP) after the 20th GW up ≥140 or 90 mmHg without proteinuria.
Treatment:
Diagnostic Test: ELISA
Control Group
Description:
Patients were normotensive at the 20th GW.
Treatment:
Diagnostic Test: ELISA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems